New Delhi, Aug. 11 -- Molbio Diagnostics IPO has entered its second day of bidding on Tuesday, 11 August. The mainboard IPO received a strong response from investors on the first day of bidding.

On the first day of bidding, the Molbio Diagnostics IPO was subscribed 83% overall, with investors placing bids for 67.5 lakh shares against the 81.58 lakh shares available for subscription.

Founded in October 2000, Molbio Diagnostics Ltd. is a global molecular diagnostics company engaged in the development, manufacturing and commercialisation of rapid diagnostic solutions for infectious and non-communicable diseases.

The company is primarily known for its proprietary Truenat platform, a portable, battery-powered PCR-based molecular diagnostic ...